283
855609226014562121
Ces38227936014570127174
Urol40217936014578115180208
2023;42547936014562121178238260
27(2):45397936014562119147205235257
78-8548227936014561120158221280
PŘEHLEDOVÉ3674207016974156235334409485586692777855
ČLÁNKY4576207016981154252352436525
18.624896013356106128
Morgan773896013389148183243294353
TM,1147896013355141164
Welty1333896013393144169203257
CHJ,1611896013364133172193
Funda1825896013353110169230281
VL,2128896013361112134
Lin228489601335276135
DW,2440896013373164180
Wright.2641896013393126150210270304325
Ductal2988898013171128176211260281
Adenocarcinoma3291898013164121173230287335384414460480537594683730
of404489801315885
the415189801313491143
Prostate:431689801315685140179213261292342359
Increased469789801312380127158208255294346405
Mortality6241048013186143174210258279300332382
Risk1028104801315677115159
and12091048013150106165
Decreased13951048013172124173203253300339391450
Serum18671048013151103133191278
Prostate2167104801315685140179213261292342
Specific25311048013151109162210231256282330
Antigen.28831048013164121152173231282339357
J32621048013138
Urol.3322104801316898154176193
2010;35371048013153104151197214
184(6):3773104801315399153181230255271
2303–7.40651048013154106157206260306312
19.6241196013356106125
Epstein7711196013355116159195249275335
JI,112911960133406790
Allsbrook1241119601336893118160222258318378430
WCJ,16941196013393155198219
Amin19361196013367158183244
MB,22021196013389148171
Egevad23961196013354114169220273335
LL,27541196013352103126
and29031196013353114176
the3101119601333797152
ISUP3276119601332679148206
Grading35051196013371107160222247307369
Committee.38971196013363122213304330365404458513535
The44551198013151111164
200546431198013153105160212
Inter‑4878119801312381113164195224
national6241348013159108140162220278327349
Society10041348013151109159180233266317
of1352134801315887
Urological14691348013169100157180238298320368418440
Pathology19401348013155103135193251274332393441
(ISUP)241213480131295099165219245
Consensus26881348013163119177216270327367423463
Conference31811348013163119178205257289340398447498
on37091348013159117
Gleason3857134801316892145193232291349
Grading42371348013168100150210232289349
of4616134801315987
Prostatic4734134801315585142182216266298320369
Carcinoma.6241498013163113145192214272331421471490
Am11471498013164154
J13341498013138
Surg14041498013152109141199
Pathol16351498013156104137196254278
[Internet].1945149801313053111143195226286339373398416
2005;23931498013154106162214229
29(9).26541498013154106135184211226
Available29131498013164111161183205254315338391
from:3337149801312962119209227
https://journals.lww.com/ajsp/Full‑3596149801316092129189230248288318342401459491550599622661681705784867882931987107711171163118512251285132213731429145114731507
text/2005/09000/The_2005_International_Society_of_Urological.15.aspx.6241648013134851331692112643153704224575085626166717267638198799329871043109411501201125612811339137014211453151215601593161516721731178018021858191119692018204020932126217722282287231523692437246825242547260526662688273627862808282628722917293329853025308431293149
20.6241796013356111133
Conteduca7791796013364122183218272334394443496
V,1297179601336277
Oromendia13961796013376112172264319380441466519
C,1936179601336488
Eng20461796013354114175
KW,22431796013360156174
et2438179601335692
al.2552179601335378101
Clinical2675179801316385106164185234283306
features3003179801312981129161219250302342
of3368179801315887
neuroendocrine34771798013159112170201258312370429487537568591648701
prostate4201179801316193149189224273305356
cancer.4580179801314999157205256287301
Eur49041798013151107138
J50651798013138
Cancer6241948013163112170219270301
Oxf9491948013174122153
Engl11271948013151108168190
1990.1341194801315398152206224
2019;15891948013154105153198216
121:1829194801315499146157
7–18.20101948013154102148195214
21.6242096013356106123
Aggarwal7662096013367127188240275358410435
R,1220209601335984
Huang13232096013372131183243304
J,1646209601334162
Alumkal1727209601336792151242292345370
JJ,2117209601334079100
et2236209601335591
al.2346209601335378100
Clinical2466209801316284105162184232281303
and27892098013149107166
Genomic29752098013168121179237326347395
Characterization33902098013162119168199248296332383414436480530562583641699
of4109209801315886
Treatment‑Emergent4215209801315175126174206295347405436465517605658689746799856887
Small‑Cell6242248013151140189212234267333384407429
Neuroendocrine10852248013171124182213270324383442501551582605663716
Prostate1834224801315586143183218268300351
Cancer:22182248013163113171220271302322
A25732248013164
Multi‑institutional26702248013186143166199221254278336375410432466524558580638697746768
Prospective3471224801315586143183243297347383405455507
Study.4010224801315283141201249263
J43052248013138
Clin4376224801316385106164
Oncol.45722248013175134183239262281
2018;48852248013154106154200218
36(24):6242398013154106134185233258275
2492–503.9232398013154101151201253304356406424
22.6242546013356112134
Bluemn778254601336086145200291351
EG,11492546013354124148
Coleman13162546013364123148203295347407
IM,17432546013326114138
Lucas19012546013351110159212255
JM,21762546013340128152
et2347254601335592
al.2458254601335379101
Androgen25792548013164122181213269329382440
Receptor30392548013156109158209268301357389
Pathway‑Independent34482548013155103135193270320366398422480539592652706763823875933965
Prostate4433254801315586142182216266298349
Cancer48022548013163112170219269301
Is624269801312362
Sustained7102698013151108147182232253311364424
through1158269801313492124180238297355
FGF15372698013151118168
Signaling.1729269801315172132189238260282339399417
Cancer21702698013163113171219270301
Cell.24962698013162113136158176
2017;26962698013154105153197210
32(4):29302698013154102128177203219
474–489.e6.31732698013154102148204261315367382435489508
23.6242846013357112134
Wang7892846013393144204266
HT,10862846013371127143
Yao12602846013359107167
YH,14582846013359131155
Li1644284601335277
BG.17522846013360131155
Neuroendocrine19392848013170124181213269323382441499549581603661714
Prostate2686284801315585142182217267299350
Cancer30682848013163113171220271302
(NEPC)3402284801313098149202264295
Progressing3729284801315586143203235286327367388446505
From4266284801315180137227
Conventional45252848013163119178225277335367389447506555577
Prostatic624299801315586143183218268300322371
Adenocarcinoma:10272998013165123177235293343393425472493551610700749766
Factors1826299801315195144180237269310
Associated21682998013165107147206255277326358409470
With26702998013191115148206
Time2909299801315176165219
to3160299801313490
Development32832998013171125174226249307368458511570602
of3917299801315987
NEPC40372998013170121174236
and43062998013150108168
Survival45062998013151108140193216266316338
From4876299801315180137227
NEPC6243148013170120174236
Diagnosis884314801317194142201259317357379417
–13263148013155
A14053148013164
Systematic1493314801315196136171222311360392414462
Review19793148013156109158181233312
and23153148013150107167
Pooled25063148013155111170193246306
Analysis.28363148013164122171193241282303342362
J32223148013138
Clin3284314801316284106163
Oncol.34723148013173132181237260278
2014;37743148013154106153200216
32(30):40143148013154103128179231258275
3383–90.43133148013154103155207262315369387
24.6243296013356108130
Park7743296013358109144195
JW,9883296013341133150
Lee11583296013351105160
JK,13383296013340100125
Sheu14823296013354114168228
KM,17303296013359149172
et1922329601335490
al.2032329601335378100
Reprogramming21513298013155108167199255315346395484572594651710
normal28813298013158116148237286307
human32083298013159116204253310
epithelial35383298013153112134167225278300321369391
tissues394932980131345694134190242282
to4251329801313489
a43603298013150
common,44303298013149104193282340398415
lethal4865329801312476109166215237
neuroendocrine6243448013159112169201257311369429487536568590648701
cancer1349344801314999156205256287
lineage.1660344801312445103156204263316333
Science.20173448013151100122175232281332349
2018;23903448013154105153200217
362(6410):26313448013153106156181231287332379406423
91–5.30783448013154102151203219
25.6243596013356112133
Epstein7843596013354116159195249275335
JI,114635960133416790
Amin12643596013367158183243
MB,15353596013388148170
Beltran17323596013360115141177212265326
H,2085359601337295
et2207359601335592
al.2326359601335379101
Proposed2455359801315586142202262302355415
Morphologic28983598013186144176237295354377435495517565
Classification3491359801316385134173213234260287336385417439497556
of4075359801315987
Prostate4190359801315586142182217267299350
Cancer45683598013163112170219270301
With48973598013191114147205
Neuroendocrine6243748013170123181212269323380440498547579602659712
Differentiation.1360374801317194123153205236288346377400448480502560618637
Am20213748013165154
J21993748013138
Surg22613748013151108139197
Pathol.24823748013155103135193252275293
2014;27993748013154105153200216
38(6):30393748013154106134184211227
756–67.32903748013154103155213270319326
26.6243896013356110133
Magers7783896013388141202257293337
MJ,11353896013389130152
Iczkowski1307389601332676125176235314357408435
KA,17623896013360131156
Montironi19383896013388149210245270305365426451
R,2409389601335984
et2514389601335591
al.2626389601335378101
MYB‑NFIB27473898013186139195229300350370425
gene31933898013160113171224
fusion3438389801312988127148206265
in3724389801312380
prostatic3826389801316092149189223273305327375
basal42233898013160110150200222
cell44673898013149100122144
carcinoma:4632389801314999130177199256315404453470
clinicopathologic62440480131497193150172220276337387419477535558616677698747
correlates14034048013149105137169221243292324375415
and18504048013150108168
comparison20504048013149105195254304335358397455514
with25964048013179102135193
basal28214048013161111151201223
cell30764048013149100123145
adenoma32534048013150109162220278368417
and37024048013150108167
florid3901404801312754112144166225
basal41584048013161111151201223
cell44134048013149100123145
hyperplasia.45904048013159105166220251312335384423445493513
Mod6244198013186144204
Pathol.8524198013156104136194252275294
2019;11704198013153105153198216
32(11):14104198013154103128175216236253
1666–74.16874198013154100154209266314359377